SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SEQUENT SCIENTIFIC

BSE: 512529 29 Jun 2025
Healthcare
₹ 183.7
Sequent Scientific Limited specializes in Pharmaceuticals within the Healthcare sector.

SEQUENT SCIENTIFIC - Share Price & Details

Market Cap
₹4,683
High /Low
241.0 / 111.0
Stock P/E
212.0
Book Value
₹28.1
Dividend Yield
0.0
ROCE
8.97
ROE
₹3.25
Face Value
2.0
PEG Ratio
-10.3
EVEBITDA
₹28.9
Debt
481
CMP / FCF
924.0
Debt to equity
₹0.68
NP Ann
32.3
High price all time
336.0
Piotroski score
₹8.0
Graham Number
23.5
No. Eq. Shares
25.0
Net CF
₹-2.15
Net profit
32.3
Price to book value
6.65
Interest Coverage
₹1.81
Low price all time
3.9
Industry PE
32.0
Reserves
₹654
Free Cash Flow
₹54.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
SEQUENT SCIENTIFIC LTD.546.042.3423.30.164,683212.0
HIKAL LTD.5529.0503.05524.04.08443248.8
Dishman Carbogen Amcis Limited7243.1430.97163.42.754383

Peer Comparison Chart


About SEQUENT SCIENTIFIC

Sequent Scientific Limited, with Security Code 512529, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Sequent Scientific Faces Mixed Signals Amid Strong Short-Term Gains and Long-Term Challenges

(06 Jun 2025)
Sequent Scientific, a small-cap pharmaceutical company, has recently experienced a shift in its technical evaluation, indicating a period of consolidation.
Read more →

SeQuent–Viyash merger clears key hurdle with Stock Exchange approvals

(04 Jun 2025)
SeQuent Scientific Ltd., a leading global player in animal health, has received approvals from both the National Stock Exchange (NSE) and...
Read more →

SeQuent–Viyash Merger Receives Stock Exchange Approvals; NCLT Filing Underway

(02 Jun 2025)
Mumbai- 2 June, 2025: Sequent Scientific (SeQuent), a leading player in the global animal health industry, has announced that it has secured...
Read more →

SeQuent Scientific and Viyash Life Sciences Secure Stock Exchange Approval for Merger Targeting Animal Health and API Integration

(29 May 2025)
SeQuent Scientific Limited and Viyash Life Sciences have received approval from stock exchanges for their proposed merger.
Read more →

Carlyle portfolio firms SeQuent Scientific and Viyash Life get stock exchange nod for merger

(29 May 2025)
Carlyle-backed SeQuent Scientific and Viyash Life Sciences have secured stock exchange approvals for their merger. Next, they will approach...
Read more →

DCX SYSTEMS LTD LEADS LOSERS IN A GROUP

(29 May 2025)
Redtape Ltd, Gujarat Fluorochemicals Ltd, Orchid Pharma Ltd and Sequent Scientific Ltd are among the other losers in the BSE's 'A' group...
Read more →